This company has shut down. TFF Pharmaceuticals is no longer operating — its last tracked round was a Post-IPO Equity in 2024.
Explore the Startup GraveyardTFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.
TFF Pharmaceuticals has raised $4.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2024.
TFF Pharmaceuticals's investors include Leidos Holdings, National Institute of Allergy and Infectious Diseases, Liquid Ventures.
TFF Pharmaceuticals is headquartered in Austin, United States.
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.
TFF Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TFF Pharmaceuticals — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/tff-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2024). TFF Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tff-pharmaceuticals
{{cite web |title=TFF Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/tff-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated